BDBM752394 (1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr- azolo[1,5-a]pyrimidin-6- yl)-1H-indol-1-yl)acetyl)- N-(3-((methoxy-d3)meth- yl-d2)-6-(trifluoromethyl)- pyridin-2-yl)-5-methyl-2- azabicyclo[3.1.0]hexane-3- carboxamide::US20250197403, Compound 80

SMILES [2H]C([2H])([2H])OC([2H])([2H])c1ccc(C(F)(F)F)nc1NC(=O)[C@@H]3C[C@@]2(C)C[C@H]2N3C(=O)Cn7cc(C(C)=O)c6cc(c5cnc4cc(C)nn4c5)cc(C)c67

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752394   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM752394((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent